nitazoxanide has been researched along with E coli Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassaganya-Riera, J; Bolick, DT; Guerrant, RL; Hontecillas, R; Nataro, JP; Roche, JK | 1 |
| Brown, SP; Guerrant, RL; Hoffman, PS; Nataro, JP; Shamir, ER; Warthan, M | 1 |
2 other study(ies) available for nitazoxanide and E coli Infections
| Article | Year |
|---|---|
Enteroaggregative Escherichia coli strain in a novel weaned mouse model: exacerbation by malnutrition, biofilm as a virulence factor and treatment by nitazoxanide.
Topics: Animals; Biofilms; Colon; Disease Models, Animal; Escherichia coli; Escherichia coli Infections; Feces; Humans; Male; Malnutrition; Mice; Mice, Inbred C57BL; Nitro Compounds; Thiazoles; Virulence; Virulence Factors; Weaning | 2013 |
Nitazoxanide inhibits biofilm production and hemagglutination by enteroaggregative Escherichia coli strains by blocking assembly of AafA fimbriae.
Topics: Adhesins, Escherichia coli; Anti-Infective Agents; Base Sequence; Biofilms; Child; Diarrhea; DNA Primers; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Fimbriae, Bacterial; Genes, Bacterial; Hemagglutination; Humans; Mutation; Nitro Compounds; Thiazoles; Virulence | 2010 |